Improving the Role of Hematopoietic Support for High-Dose Cytotoxic Therapy

References

• Gulati Yahalom S., Portlock J. C. Autologous bone marrow transplantation. Current Problems in Cancer, Vol 15, CN Haskell. Mosby Yearbook, St Louis 1991; 1–57
   Google Scholar
• Proceeding of the 5th International AUBMT Symposium. 1991, K Dicke, A. Armitage, J. Dicke, MJ. Evinger. The University of Nebraska Medical Center, Omaha 1991
   Google Scholar
• Progress in Clinical and Biological Research, Bone Marrow Purging and Processing, Vol 333, S Gross, A P Gee, D A Worthington-White. Alan R Liss, New York 1990
   Google Scholar
• Gribben G J, Freedman A S, Neuberg D. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 1991; 325: 1525–1533
   PubMed Web of Science ®Google Scholar
• Jones J., Ambinder RE, Piantadosi S. Evidence of a graft-verbus-lymphoma effect associated with allogenic bonc marrow transplantation. Blood 1991; 77: 649–653
   PubMed Web of Science ®Google Scholar
• Rowley S, Jones C. RJ., Piantadosi S. Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia. Blood 1989; 74: 501–506
   PubMed Web of Science ®Google Scholar
• Gianni A M, Bregni M., Siena S. Recombinant human gran-ulocyte-macrophage colony-stimulating factor reduces hemato-logic toxicity and widens clinical applicability of high-dose cy-clophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol 1990; 8: 768–778
   PubMed Web of Science ®Google Scholar
• Moss TJ., Sanders D G. Detection of neuroblastonia cells in blood. J Clin Oncol 1990; 8: 736–740
   PubMed Web of Science ®Google Scholar
• Kohler S., Galili N., Sklar J L. Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia. Leukemia 1990; 4: 541–547
   PubMed Web of Science ®Google Scholar
• Tkachuk D, Westbrook C. C, Andreeff A. M. Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science 1990; 250: 559–561
   PubMed Web of Science ®Google Scholar
• Janseen W, Farmelo E. M, Lee J. C. The CD34+ cell fraction in bone marrow and blood is not universally predictive of CFU-GM. Exp Hematol 1992; 20: 528–530
   PubMed Web of Science ®Google Scholar
• Juttner CA., To L B, Haylock DN., Dyson P C. Peripheral blood stem cell selection, collection and autotransplantation. Progress in Clinical and Biological Research, Bone Marrow Purging and Processing. Vol 333, S Gross, AP Gee, DA Worthington-White. Alan R Liss, New York 1990
   Google Scholar
• Stiff P, De J., Risi M F, Langleben A. Autologous bone marrow transplantation using unfractionated cells without rate-controlled freezing in hydroxyethyl starch and dimethyl sulfoxide. Ann NY Acad Sci 1983; 411: 378–380
   PubMed Web of Science ®Google Scholar
• Weiden P L, Sullivan K, Floumoy M. N. Antileukemic effect of chronic graft-versus-host disease. N Engl J Med 1981; 304: 1529
   PubMed Web of Science ®Google Scholar
• Horowitz M M, Gale R P, Sondel P M. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555
   PubMed Web of Science ®Google Scholar
• Frame J N, Collins N H, Cartagena T. N. A. T Cell depletion of human bone marrow. Comparison of Campath-I plus complement, anti-T cell rich A chain immunotoxin and soybean ag-glutinin alone or in combination with sheep erythrocytes or im-munomagnetic beads. Transplantation 1989; 47: 984–988
   PubMed Web of Science ®Google Scholar
• Gale R P, Horowitz M M. Graft-versus-leukemia in bone marrow transplantation. Blood 1990; 76: 555–562
   PubMedGoogle Scholar
• Mackinnon S, Hows JM., Goldman J M. Induction of in-vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia. Blood 1990; 76: 2037–2045
   PubMed Web of Science ®Google Scholar
• Carella A M, Gaozza E, Conglu A. Cyclosporine-induced graft-versus-host disease after autologous bone-marrow transplantation in hematological malignancies. Ann Hematol 1991; 62: 156–159
   PubMed Web of Science ®Google Scholar
• Charak B S, Brynes R K, Groshen S. Bone marrow transplantation with interleukin-2-activated bone marrow followed by interleukin-2 therapy for acute myeloid leukemia in mice. Blood 1990; 76: 2187–2190
   PubMed Web of Science ®Google Scholar
• Shapiro R, Chauvenant S. A, McGuire W. Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamaglobulin. N Engl J Med 1988; 318: 1344
   Google Scholar
• Hagenbeek A, Schultz F W, Martens A CM. In vitro or in vivo treatment of leukemia to prevent a relapse after autologous bone marrow transplantation. Autologous Bone Marrow Transplantation: Proc Fourth International Symposium, KA Dicke, G Spitzer, S Jagannath. MD Anderson Hospital, Houston 1989; 107–112
   Google Scholar
• Gulati S C, Lemoli R M, Acaba L. Purging in autologous and allogeneic bone marrow transplantation. Curr Opin Oncol 1992; 4: 264–271
   PubMedGoogle Scholar
• Turhan AC., Humphries R K, Eaves C J. Detection of breakpoint cluster region negative and nonclonal hematopoiesis in-vitro and in-vivo after transplantation of cells selected in cultures of chronic myeloid leukemia marrow. Blood 1990; 76: 2404–2410
   PubMed Web of Science ®Google Scholar
• Chang J., Morgenstern G R, Coutino L H. The use of bone marrow transplantation in acute niyeloid leukemia. An update. Bone Marrow Transplant 1989; 4: 5–9
   PubMed Web of Science ®Google Scholar
• Lemoli R M, Tafuri Stife A., Andreff A. M, Clarkson BD., Gulati S C. Proliferation of human hematopoietic progenitors in long-term bone marrow cultures in gas-permeable plastic bags is enhanced by colony-stimulating factors. Exp Hematol 1992; 20: 323–329
   Google Scholar
• Pole G, Casper J. I, Elfenbein G. High-dosc chemoradio-therapy supported by marrow infusions for advanced neuroblas-toma: A pediatric oncology group study. J Clin Oncol 1991; 19: 152–158
   Google Scholar
• Sieber F., Spivak J L, Sutcliffe A M. Selective killing of leukemic cells by merocyanine 540-mediated photosensitization. Proc Natl Acad Sci USA 1984; 81: 7584
   PubMed Web of Science ®Google Scholar
• Atzpodien J., Gulati S C, Strife A. Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts. Blood 1987; 70: 484–489
   PubMed Web of Science ®Google Scholar
• Long G S, Cramer D V, Harnaha J B. Lymphokine-activated killer (LAK) cell purging of leukemic bone marrow: range of activity against different hematopoietic neoplasms. Bone Marrow Transplant 1990; 6: 169–177
   PubMed Web of Science ®Google Scholar
• Szczylik C, Skorski T, Nicolaides N C. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligode-oxynucleotides. Science 1991; 253: 562–565
   PubMed Web of Science ®Google Scholar
• Smoluk G D, Fdhey R C. Radioprotection of cells in culture by WR-2721 and derivatives: Form of the drug responsible for protection. Cancer Res 1988; 48: 3641–3647
   PubMed Web of Science ®Google Scholar
• Uckun F, Kersey M. JH., Vallera D A. Autologous bone marrow transplantation in high risk remission T-lineage acute lym-phoblastic leukemia using immunotoxins plus 4-Hydroperoxycy-clophospharnide for marrow purging. Blood 1990; 76: 1723–1733
   PubMed Web of Science ®Google Scholar
• Aihara M, Sikic B I, Blume K G. Assessment of purging with multidrug resistance (MDR) modulators and VP-16: Results of long-term marrow culture. Exp Hematol 1990; 18: 940–944
   PubMed Web of Science ®Google Scholar
• To LB., Haylock D N, Dyson P G. An unusual pattern of hemopoietic reconstitution in patients with acute myeloid leukemia transplanted with autologous recovery phase peripheral blood. Bone Marrow Transplant 1990; 6: 109–114
   PubMed Web of Science ®Google Scholar
• Fleischhauer Keman K., Nancy, O'Rielly R J. Bone marrow-allograft rejection by T-lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 1990; 323: 1818–1822
   PubMed Web of Science ®Google Scholar